Ameriprise Financial Inc Concert Pharmaceuticals, Inc. Transaction History

Ameriprise Financial Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$4.86 - $13.07 $122,428 - $329,246	-25,191 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$9.48 - $12.84 $108,147 - $146,478	-11,408 Reduced 31.17%	25,191 $318,000
Q3 2020 Nov 16, 2020	SELL	$8.67 - $10.82 $17,574 - $21,932	-2,027 Reduced 5.25%	36,599 $359,000
Q2 2020 Aug 14, 2020	SELL	$7.8 - $11.52 $3,003 - $4,435	-385 Reduced 0.99%	38,626 $384,000
Q1 2020 May 15, 2020	BUY	$5.98 - $13.09 $11,577 - $25,342	1,936 Added 5.22%	39,011 $345,000
Q4 2019 Feb 14, 2020	BUY	$5.71 - $9.22 $211,698 - $341,831	37,075 New	37,075 $342,000

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Ameriprise Financial Inc with notifications on news.